I am frustrated by some of these previous remarks. Why did you invest in a company that has laid claim to a universal cancer marker when you now think it is a bad thing that will have no use in medicine. I have tremendous respect for most of the contributors on this board, but how can this suddenly be a sticking point? Recaf will be of great use to doctors in the future. Most insurance companies will insist on Recaf as will the informed public at large, and especially countries where they have socialized medicine. Recaf doesn't just work just in the US!
News 
Market Data 
Discover 
AI
